Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Naoya Kato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8233-5426; OpenAlex author ID A5049839760. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurre… Co-author DOI 10.1200/jco.24.00936↗
  2. Factors Affecting Patency of Uncovered Duodenal Stents in Malignant Duodenal Stenosis Due to Pancreatic Cancer: A Retrospective Cohort Study. Last author DOI 10.7759/cureus.77245↗
  3. Endoscopic Ultrasound Criteria for Arterial Invasion in Pancreatic Cancer of the Body and Tail. Last author DOI 10.1097/mpa.0000000000001523↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroshi Ohyama · 2 shared papers, 2020–2025 · strength 0.46
  2. Koji Takahashi · 1 shared paper, 2025 · strength 0.37
  3. Ayako Shingyoji · 1 shared paper, 2020 · strength 0.10
  4. Mutsumi Yamato · 1 shared paper, 2020 · strength 0.10
  5. Takashi Kishimoto · 1 shared paper, 2020 · strength 0.10
  6. Rintaro Mikata · 1 shared paper, 2020 · strength 0.10
  7. Hideyuki Yoshitomi · 1 shared paper, 2020 · strength 0.10
  8. Masayuki Ohtsuka · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.